Longevity.Technology (@LongevityTech)· LongevityTech·· 2 小时前评分8
VectorY扩大PIONEER-ALS试验规模
VectorY is growing PIONEER-ALS from 12 to 36 participants to test VTx-002, an antibody therapy aimed at the protein TDP-43.
导读
VectorY将PIONEER-ALS试验从12名受试者扩大到36名，以测试VTx-002——一种针对TDP-43蛋白的抗体疗法。 https://vist.ly/5p7v2 #longevity #geroscience #vectory #pioneerals #vtx002
来源：Longevity.Technology (@LongevityTech) · x.com